-
1
-
-
0028258794
-
How many people in the world have multiple sclerosis?
-
Dean G.. How many people in the world have multiple sclerosis?. Neuroepidemiology. 1994 ; 13: 1-7 (Pubitemid 24107445)
-
(1994)
Neuroepidemiology
, vol.13
, Issue.1-2
, pp. 1-7
-
-
Dean, G.1
-
2
-
-
25844455292
-
Regional variation of multiple sclerosis prevalence in Canada
-
DOI 10.1191/1352458505ms1192oa
-
Beck CA, Metz LM, Svenson LW, et al. Regional variation of multiple sclerosis prevalence in Canada. Mult Scler. 2005 ; 11: 516-519 (Pubitemid 41387694)
-
(2005)
Multiple Sclerosis
, vol.11
, Issue.5
, pp. 516-519
-
-
Beck, C.A.1
Metz, L.M.2
Svenson, L.W.3
Patten, S.B.4
-
3
-
-
33746588738
-
The epidemiology of multiple sclerosis in Europe
-
DOI 10.1111/j.1468-1331.2006.01342.x
-
Pugliatti M, Rosati G, Carton H, et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol. 2006 ; 13: 700-722 (Pubitemid 44143944)
-
(2006)
European Journal of Neurology
, vol.13
, Issue.7
, pp. 700-722
-
-
Pugliatti, M.1
Rosati, G.2
Carton, H.3
Riise, T.4
Drulovic, J.5
Vecsei, L.6
Milanov, I.7
-
4
-
-
76649141745
-
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba
-
Marrie RA, Yu N, Blanchard JF, et al. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology. 2010 ; 74: 465-471
-
(2010)
Neurology
, vol.74
, pp. 465-471
-
-
Marrie, R.A.1
Yu, N.2
Blanchard, J.F.3
-
6
-
-
77953332151
-
Socioeconomic trends in hospitalization for multiple sclerosis
-
Lad S, Chapman C, Vaninetti M, et al. Socioeconomic trends in hospitalization for multiple sclerosis. Neuroepidemiology. 2010 ; 35: 93-99
-
(2010)
Neuroepidemiology
, vol.35
, pp. 93-99
-
-
Lad, S.1
Chapman, C.2
Vaninetti, M.3
-
7
-
-
34347257728
-
Health status and health care utilization of multiple sclerosis in Canada
-
Pohar SL, Jones CA, Warren S, et al. Health status and health care utilization of multiple sclerosis in Canada. Can J Neurol Sci. 2007 ; 34: 167-174 (Pubitemid 47000118)
-
(2007)
Canadian Journal of Neurological Sciences
, vol.34
, Issue.2
, pp. 167-174
-
-
Pohar, S.L.1
Jones, C.A.2
Warren, S.3
Turpin, K.V.L.4
Warren, K.5
-
8
-
-
33746316226
-
Costs and quality of life of patients with multiple sclerosis in Europe
-
DOI 10.1136/jnnp.2006.090365
-
Kobelt G, Berg J, Lindgren P, et al. Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2006 ; 77: 918-926 (Pubitemid 44174075)
-
(2006)
Journal of Neurology, Neurosurgery and Psychiatry
, vol.77
, Issue.8
, pp. 918-926
-
-
Kobelt, G.1
Berg, J.2
Lindgren, P.3
Fredrikson, S.4
Jonsson, B.5
-
9
-
-
79957643199
-
Health service utilization in IBD: Comparison of self-report and administrative data
-
Longobardi T, Walker J, Graff L, et al. Health service utilization in IBD: Comparison of self-report and administrative data. BMC Health Serv Res. 2011 ; 11: 137
-
(2011)
BMC Health Serv Res
, vol.11
, pp. 137
-
-
Longobardi, T.1
Walker, J.2
Graff, L.3
-
10
-
-
84894892822
-
Measurement of health care utilization in Canada: Agreement between surveys and administrative records
-
Palin J, Zumbo BD.. Measurement of health care utilization in Canada: Agreement between surveys and administrative records. Statistics Canada International Symposium Series ; 2005 Gatineau, Quebec, Canada ; 2005..
-
Statistics Canada International Symposium Series
-
-
Palin, J.1
Zumbo, B.D.2
-
11
-
-
0033048129
-
First hospital-admission rate as an epidemiological indicator for patients with multiple sclerosis in Stockholm, 1984-1993
-
Jiang G-X, Cheng Q, Fredrikson S, et al. First hospital-admission rate as an epidemiological indicator for patients with multiple sclerosis in Stockholm, 1984-1993. Acta Neurol Scand. 1999 ; 100: 64-68 (Pubitemid 29292553)
-
(1999)
Acta Neurologica Scandinavica
, vol.100
, Issue.1
, pp. 64-68
-
-
Jiang, G.-X.1
Cheng, Q.2
Fredrikson, S.3
Link, H.4
-
13
-
-
76649131513
-
-
Winnipeg: Manitoba Health and Healthy Living;
-
Population report. Winnipeg: Manitoba Health and Healthy Living ; 2008:
-
(2008)
Population Report
-
-
-
15
-
-
0004292914
-
-
2nd ed.Philadelphia: Lippincott Williams & Wilkins, 1998, p.738. Philadelphia: Lippincott Williams & Wilkins;
-
Rothman KJ, Greenland S. Modern epidemiology. 2 nd ed.Philadelphia: Lippincott Williams & Wilkins, 1998, p.738. Philadelphia: Lippincott Williams & Wilkins ; 1998: 738.
-
(1998)
Modern Epidemiology
, pp. 738
-
-
Rothman, K.J.1
Greenland, S.2
-
16
-
-
34249723173
-
Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database
-
Prescott JD, Factor S, Pill M, et al. Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database. J Manag Care Pharm. 2007 ; 13: 44-52 (Pubitemid 46824250)
-
(2007)
Journal of Managed Care Pharmacy
, vol.13
, Issue.1
, pp. 44-52
-
-
Prescott, J.D.1
Factor, S.2
Pill, M.3
Levi, G.W.4
-
17
-
-
26444454498
-
Changes in the ascertainment of multiple sclerosis
-
DOI 10.1212/01.wnl.0000178891.20579.64
-
Marrie RA, Cutter G, Tyry T, et al. Changes in the ascertainment of multiple sclerosis. Neurology. 2005 ; 65: 1066-1070 (Pubitemid 41429632)
-
(2005)
Neurology
, vol.65
, Issue.7
, pp. 1066-1070
-
-
Marrie, R.A.1
Cutter, G.2
Tyry, T.3
Hadjimichael, O.4
Campagnolo, D.5
Vollmer, T.6
-
18
-
-
0027418515
-
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
-
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology. 1993 ; 43: 655-661
-
(1993)
Neurology
, vol.43
, pp. 655-661
-
-
-
19
-
-
33644608613
-
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
-
Rudick RA, Stuart WH, Calabresi PA, et al. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. New Engl J Med. 2006 ; 354: 911-923
-
(2006)
New Engl J Med
, vol.354
, pp. 911-923
-
-
Rudick, R.A.1
Stuart, W.H.2
Calabresi, P.A.3
-
20
-
-
78649495042
-
All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States
-
Asche CV, Singer ME, Jhaveri M, et al. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States. J Manag Care Pharm. 2010 ; 16: 703-712
-
(2010)
J Manag Care Pharm
, vol.16
, pp. 703-712
-
-
Asche, C.V.1
Singer, M.E.2
Jhaveri, M.3
-
21
-
-
79960147043
-
Association between comorbidity and clinical characteristics of MS
-
Marrie RA, Horwitz RI, Cutter G, et al. Association between comorbidity and clinical characteristics of MS. Acta Neurol Scand. 2011 ; 124: 135-141
-
(2011)
Acta Neurol Scand
, vol.124
, pp. 135-141
-
-
Marrie, R.A.1
Horwitz, R.I.2
Cutter, G.3
-
22
-
-
55849095479
-
Economic burden prior to COPD diagnosis: A matched case-control study in the United States
-
Akazawa M, Halpern R, Riedel A, et al. Economic burden prior to COPD diagnosis: A matched case-control study in the United States. Respir Med. 2008 ; 102: 1744-1752
-
(2008)
Respir Med
, vol.102
, pp. 1744-1752
-
-
Akazawa, M.1
Halpern, R.2
Riedel, A.3
-
23
-
-
79951588974
-
Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia
-
Sanchez RJ, Uribe C, Li H, et al. Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin. 2011 ; 27: 663-671
-
(2011)
Curr Med Res Opin
, vol.27
, pp. 663-671
-
-
Sanchez, R.J.1
Uribe, C.2
Li, H.3
-
24
-
-
0036292391
-
Application of the new Mcdonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis
-
DOI 10.1002/ana.10240
-
Dalton CM, Brex PA, Miszkiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol. 2002 ; 52: 47-53 (Pubitemid 34693742)
-
(2002)
Annals of Neurology
, vol.52
, Issue.1
, pp. 47-53
-
-
Dalton, C.M.1
Brex, P.A.2
Miszkiel, K.A.3
Hickman, S.J.4
MacManus, D.G.5
Plant, G.T.6
Thompson, A.J.7
Miller, D.H.8
-
25
-
-
77953394241
-
Multiple sclerosis: Risk factors, prodromes, and potential causal pathways
-
Ramagopalan SV, Dobson R, Meier UC, et al. Multiple sclerosis: Risk factors, prodromes, and potential causal pathways. Lancet Neurol. 2010 ; 9: 727-739
-
(2010)
Lancet Neurol
, vol.9
, pp. 727-739
-
-
Ramagopalan, S.V.1
Dobson, R.2
Meier, U.C.3
|